Twelve Leveraged Anthropic ETFs Are Armed Before a Single Share Trades — and the Bid Comes From a Tape That Just Fell 5.5%

Retail leverage has reached a frontier AI lab before that lab reached the market. Twelve single-stock Anthropic ETFs have prospectuses on file with the SEC, dated from Oct. 27 to Nov. 6, and ProShares' 2x and -2x pair accounts for two of them. Five funds target twice Anthropic's daily move, five target minus twice, one targets the inverse daily move and one is a covered-call income fund. Half the complex is built to profit from the print falling — an unusual position for a company with an 85% gross margin and $16.29 billion of first-half revenue.

The earliest dates in circulation are Nov. 13 for pricing and Nov. 16 for the first trade, with the roadshow starting in the week of Nov. 9. Institutional conversations already point below the $1.5 trillion mark discussed at Anthropic's investor day, with one investor telling CNBC that $1.0 trillion to $1.25 trillion looks more likely. ProShares' Nov. 6 effective date sits inside that gap, which means the leveraged money arrives with the listing rather than ahead of it — and therefore arrives into whatever the first sessions of trading deliver.

This is what the wrappers actually change. A -2x fund does not sit still when Anthropic rallies; it must buy its short back to restore its target exposure, and a +2x fund must add. On an up day both cohorts are buyers, and on a down day both are sellers. The complex amplifies whichever direction the debut takes instead of hedging it, which turns the first price into a reflexive flow artifact before it is a clean valuation verdict — and that is precisely the risk the retail buyer is being sold.

The flows that will set Anthropic's first price have to come from a market that just repriced the AI complex hard. On Nov. 5 the Nasdaq Composite fell more than 5.5%, its steepest drop in 19 months, and the Nasdaq 100 lost 6.3% while erasing $2.3 trillion of value; the S&P 500 fell 4.4% and erased $2.8 trillion. The two indices together shed about $5.1 trillion in one session, with the trigger political rather than operational: midterm candidates promising to rein in AI data centers.

Build the multiple carefully. Anthropic's trailing revenue through the third quarter of 2026 is about $36.5 billion: $3.4 billion in the second half of 2025 (full-year $4.6 billion less first-half $1.2 billion), plus $16.29 billion in the first half of 2026 and $16.8 billion in the third quarter. At a $1.5 trillion valuation that is roughly 41x trailing sales, against 16.1x for Broadcom, 14.9x for Nvidia, 9.3x for CoreWeave, 7.6x for Alphabet and 3.8x for Amazon on the same trailing basis.

The chips that make Anthropic's growth possible are financed by lenders who get paid in Anthropic equity. Broadcom will lend up to $42 billion against a five-year TPU lease of $125.2 billion, with the notes convertible into Anthropic shares, paying 9.00% interest in kind and converting at 90% of the 30-day VWAP. Blackstone was offered more than 10 percent to anchor a $60 billion chip financing package. Every rally in Anthropic hands those lenders stock at a discount to the market, which turns a squeeze into new supply — the opposite of what a leveraged long holder needs.

In days to quarters the drivers are dated and knowable: pricing on or after Nov. 13, the first trade on or after Nov. 16, the size of the retail tranche, whether Nvidia's anchor converts, and whether the tape stabilises enough to absorb a 41x multiple. The sequencing is what matters — a leveraged complex switching on into a falling market is a seller, not a buyer, and the same 12 funds that would have chased a hot debut will be liquidating into a soft one.

Over one to three years the mechanical supply arrives on a schedule. Founders can transfer 29% of their Anthropic stock about 180 days after trading begins, with the remainder a year later, and the seven co-founders hold 50.1% of the voting power through a single Class F share. Meanwhile the compute obligations run to 2033 and 2036, so revenue is contracted while equity is not. The leveraged holder is short a supply schedule — trading into a known release calendar rather than an unknown one, with the first meaningful tranche about six months after listing.